Melinta Therapeutics to Report First Quarter 2018 Financial Results on May 8, 2018

NEW HAVEN, Conn., April 27, 2018 (GLOBE NEWSWIRE) — Melinta Therapeutics, Inc. (NASDAQ:MLNT), a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious bacterial infections, today announced it intends to release its first quarter 2018 financial results on May 8, 2018, following the closing of the U.S. financial markets.
Melinta will host a conference call and live webcast on Tuesday, May 8, 2018 at 4:30 p.m. ET to discuss its financial results and provide a business update.